Hemostemix Inc. announced the appointment of David Wood to the position of Chairman, Bryson Goodwin to the position of Chief Executive Officer, Thomas Smeenk to the position of President, and Natasha Sever to the position of Chief Financial Officer. Yari Nieken will replace Angus Jenkins, who recently resigned from the Company. Mr. Nieken is an independent director.

The Directors appointed the Audit Committee and the Compensation Committee. Mr. Wood is an independent director of the Company and has a wide range of public company experience.  Most recently Mr. Wood sat on the board of directors from 1997 until the completion of its change of business transaction in October 2019 of Black Bull Resources Inc., a former mining company, which is now listed on the TSXV under the name Magnetic North Acquisitions Corp. Mr. Goodwin is a practiced international executive with extensive experience in finance, management, investor relations and operations with both private and public companies.

Mr. Smeenk was the Founder, a Director, President and Vice-President, Business Development for TheraVitae Inc., which was taken over by Hemostemix Inc. as its Qualifying Transaction.  Mr. Smeenk is a project finance and business development executive with a proven track record of bringing new discoveries to market.